United States · Funded startup

Who invested in Imprimis Pharmaceuticals

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$23Mraised across 2 rounds since 2012, from 2 sources

$7.9MGrowth$15MDebt
Latest round
Debt, $15MMay 2015
Step-upi
1.9×
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201320142015
$7.9MGrowth$15MDebt
First round
Growth, $7.9M
May 2012
Biggest round
$15M
Debt · May 2015
Between rounds
3 years
from the last two

The rounds

  1. May 2015
    Debt$15M1 new

    From a historical funding recordSEC filing: $500K sold, first sale Jan 2015

  2. May 2012
    Growth$7.9M

    No investor was named in the report.

    Reported by sec.govSEC filing: $7.9M sold, first sale Apr 2012

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Imprimis Pharmaceuticals

Who invested in Imprimis Pharmaceuticals?

Imprimis Pharmaceuticals's investors include Life Sciences Alternative Funding.

How much has Imprimis Pharmaceuticals raised?

Imprimis Pharmaceuticals has raised $23M across 2 rounds since 2012.

When did Imprimis Pharmaceuticals last raise?

Imprimis Pharmaceuticals's most recent round was a Debt of $15M in May 2015.

What was Imprimis Pharmaceuticals's biggest round?

Its most recent round, $15M in May 2015, is also its largest on record.

Who backed Imprimis Pharmaceuticals first?

Imprimis Pharmaceuticals's first round on record, in May 2015, was backed by Life Sciences Alternative Funding.

What stage is Imprimis Pharmaceuticals at?

Imprimis Pharmaceuticals's latest named round is a Debt, in May 2015.

Where is Imprimis Pharmaceuticals based?

Imprimis Pharmaceuticals is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.